0 comments

Stage Two: Let the Debate Begin!

Many of us who are close to healthcare IT regulation will soon be heads-down reviewing, analyzing and generally mulling over the Proposed Rule on Stage 2 of the Meaningful Use program, now that CMS is set to release it.  On top of late nights and a headache or two, there is one other thing we’re bracing for: the Great Debate as to whether CMS – with significant input from others – did a good job or missed the mark.  No matter what is in the Rule, some will argue that the proposed measures are too difficult, while others will insist CMS didn’t go far enough.  It’s clear we can expect significant back-and-forth on the appropriate balance of the Rule’s many elements – the thresholds, the quality measures, the requirements for data connectivity, privacy elements, and how best to measure patient engagement in […]